Chemipharm Executive and Leadership Team

Karim Kamel, the Chief Executive Officer at Chemipharm, directs the overarching corporate strategy and long-term vision for the organization. By overseeing the transition from a private sector importer to a comprehensive manufacturer, the Chief Executive Officer ensures alignment between production capabilities and market demand. This leadership role involves managing the expansion of sterile production areas for ampoules and eye drops to capture broader market segments. Karim Kamel maintains rigorous oversight of the 6th of October Industrial Zone facility, ensuring all operations meet international GMP standards. Through constant evaluation of the pharmaceutical landscape, the Chief Executive Officer identifies growth opportunities that solidify the company's reputation as a premier distributor. By fostering innovation in product forms, the Chief Executive Officer secures the competitive advantage necessary for sustained success within the Egyptian healthcare sector, ultimately driving the company toward future milestones in pharmaceutical manufacturing and distribution excellence.

Rafik Nessim, the Chief Operating Officer at Chemipharm, manages the daily execution of the company's extensive distribution network. Overseeing 12 branches and 100 fixed daily routes, the Chief Operating Officer ensures that pharmaceutical products reach 100% of reachable pharmacies and hospitals across Egypt. This role requires precise coordination of logistics to maintain the high standards associated with the brand. Rafik Nessim optimizes the supply chain to guarantee timely delivery of tablets, capsules, and syrups to every corner of the country. By monitoring the performance of the 150 visiting representatives, the Chief Operating Officer maintains direct engagement with the retail and clinical market. This operational focus supports the company's mission to provide reliable access to essential medications. Through the implementation of efficient distribution protocols, the Chief Operating Officer sustains the company's market dominance and ensures that the logistical infrastructure remains robust enough to support ongoing national growth.

Nedal Melika, the Deputy Chief Operating Officer at Chemipharm, supports the internal scaling of manufacturing operations and facility management. Focusing on the technical requirements of the 6th of October Industrial Zone plant, the Deputy Chief Operating Officer ensures that production lines for tablets and ointments operate at peak efficiency. This leadership role involves coordinating with engineering teams to integrate new sterile production capabilities for antibiotics and eye drops. Nedal Melika monitors quality control protocols to uphold the company's reputation for high-standard pharmaceutical production. By streamlining internal processes, the Deputy Chief Operating Officer reduces manufacturing bottlenecks and enhances output capacity. This position requires close collaboration with the Chief Operating Officer to align production schedules with the demands of the national distribution network. Through meticulous oversight of facility maintenance and technological upgrades, the Deputy Chief Operating Officer contributes to the continuous improvement strategy that defines the company's manufacturing success.

Doulas Oliver, the President at Chemipharm, governs the corporate structure and oversees the strategic implementation of business development initiatives. By managing high-level relationships with stakeholders and industry partners, the President ensures that the company maintains its status as a leader in the Egyptian pharmaceutical market. This role involves analyzing market trends to guide the expansion of the product portfolio and the development of new sterile manufacturing areas. Doulas Oliver directs the alignment of corporate policies with the company's mission of continuous growth and improvement. By fostering a culture of excellence, the President supports the executive team in achieving operational targets across both manufacturing and distribution divisions. This leadership position requires a deep understanding of the pharmaceutical industry to navigate regulatory environments and competitive pressures. Through strategic planning and governance, the President secures the long-term stability and market impact of the organization, ensuring that the company remains the most respectable distributor in the region.